S. Janke

Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility

Thomas Streichert, K. Milde-Langosch, F. Jänicke, 2008, Breast Cancer Research and Treatment.

A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131.

K. Gelmon, D. Ayers, L. Seymour, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.